Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

Pharmaceutical Poisoning: Treatment Strategies

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...

Dosage Regimen: Individualization

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Designing 3D-Printed TiO<sub>2</sub>/BiFeO<sub>3</sub>-Hybrid Materials for Enhanced Photocatalytic Degradation of Acyclovir via Visible Light.

ACS applied materials & interfaces·2026

Same author

Unveiling Surface Species Formed on Ni-Fe Spinel Oxides During the Oxygen Evolution Reaction at the Atomic Scale.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025

Same author

Kinetics of Direct Reaction of Vanadate, Chromate, and Permanganate with Graphene Nanoplatelets for Use in Water Purification.

Nanomaterials (Basel, Switzerland)·2024

Same author

Tunable Syngas Formation at Industrially Relevant Current Densities via CO<sub>2</sub> Electroreduction and Hydrogen Evolution over Ni and Fe-derived Catalysts obtained via One-Step Pyrolysis of Polybenzoxazine Based Composites.

Small (Weinheim an der Bergstrasse, Germany)·2024

Same author

N-Doped porous carbons obtained from chitosan and spent coffee as electrocatalysts with tuneable oxygen reduction reaction selectivity for H<sub>2</sub>O<sub>2</sub> generation.

RSC advances·2023

Same author

Linking Composition, Structure and Thickness of CoOOH layers to Oxygen Evolution Reaction Activity by Correlative Microscopy.

Angewandte Chemie (International ed. in English)·2023

Search research articles

Related Experiment Video

Updated: Jun 21, 2026

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

[Novel therapeutics risk management].

Ulrich Hagemann¹

¹Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), Bonn. hagemann@bfarm.de

Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen

|August 4, 2009

Summary

This summary is machine-generated.

Pharmacovigilance identifies and mitigates risks for new medicines, adhering to the precautionary principle. Risk management plans are crucial tools, detailing drug risks, safety plans, and communication strategies.

More Related Videos

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

Related Experiment Videos

Last Updated: Jun 21, 2026

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

Area of Science:

Pharmacovigilance and Drug Safety
Regulatory Science

Context:

The identification and assessment of risks associated with new or innovative medicines are paramount.
Pharmacovigilance activities are guided by the 'precautionary principle' to ensure patient safety.

Purpose:

To highlight the critical role of risk identification, assessment, and mitigation in pharmacovigilance.
To introduce Risk Management Plans (RMPs) as a novel tool for achieving pharmacovigilance goals.

Summary:

Risk Management Plans (RMPs) are essential for modern pharmacovigilance.
Key components of RMPs include drug-specific risk profiles, comprehensive pharmacovigilance plans, and effective risk communication protocols.

Impact:

Enhances the safety profile of new and innovative medicines.
Provides a structured framework for proactive risk management in pharmaceutical development and post-marketing surveillance.